Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia

Drug and Alcohol Dependence

Volumn 153, Issue , 2015, Pages 43-49

  Winter, R J ^a,b   Stoove M ^a,b   Degenhardt, L ^c,d   Hellard, M E ^a,b   Spelman, T ^a,b,e   Jenkinson, R ^a,f   McCarthy, D R ^a   Kinner, S A ^b,d,g  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e PETER DOHERTY INSTITUTE FOR INFECTION AND IMMUNITY   (Australia)

^f AUSTRALIAN INSTITUTE OF FAMILY STUDIES   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Drug overdose; Drug users; Injecting drug use; Prisoners

Indexed keywords

NALOXONE;

ALCOHOL CONSUMPTION; ARTICLE; AUSTRALIA; DISTRESS SYNDROME; DRUG OVERDOSE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MEDICAL HISTORY; MISCELLANEOUS NAMED GROUPS; MORBIDITY; OPIATE SUBSTITUTION TREATMENT; PEOPLE WHO INJECT DRUG; PREDICTION; PRIORITY JOURNAL; PRISON; PRISONER; SELF REPORT; STRUCTURED INTERVIEW; ADULT; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SUBSTANCE ABUSE; TRENDS;

ADULT; DRUG OVERDOSE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRISONERS; PRISONS; QUEENSLAND; RISK FACTORS; SELF REPORT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84937640139     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.06.011     Document Type: Article

References (54)

1. Aitken C.K., Lewis J., Tracy S., Spelman T., Bowden D.S., Bharadwaj M., Drummer H., Hellard M.E. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 2008, 48:1746-1752.
2. Andrews G., Slade T. Interpreting scores on the Kessler Psychological Distress Scale (K10). Aust. N. Z. J. Public Health 2001, 25:494-497.
3. Australian Institute of Health and Welfare The Health of Australia's Prisoners 2012 2013, Cat. no. PHE 170, Australian Institute of Health and Welfare, Canberra.
4. Babor T.F., Higgins-Biddle J.C., Saunders J.B., Monteiro M.G. AUDIT: The Alcohol Use Disorders Identification Test. Guidelines for Use in Primary Care 2001, World Health Organisation, Geneva. second ed.
5. Bartoli F., Carrà G., Brambilla G., Carretta D., Crocamo C., Neufeind J., Baldacchino A., Humphris G., Clerici M. Association between depression and non-fatal overdoses among drug users: a systematic review and meta-analysis. Drug Alcohol Depend. 2014, 134:12-21.
6. Binswanger I.A., Stern M.F., Deyo R.A., Heagerty P.J., Cheadle A., Elmore J.G., Koepsell T.D. Release from prison - a high risk of death for former inmates. N. Engl. J. Med. 2007, 356:157-165.
7. Binswanger I.A., Nowels C., Corsi K.F., Glanz J., Long J., Booth R.E., Steiner J.F. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict. Sci. Clin. Pract. 2012, 7:3. 10.1186/1940-0640-7-3.
8. Binswanger I.A., Blatchford P.J., Mueller S.R., Stern M.F. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann. Intern. Med. 2013, 159:592-600.
9. Bird S.M., Hutchinson S.J. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99. Addiction 2003, 98:185-190.
10. Brugal M.T., Barrio G., Fuente L.D.L., Regidor E., Royuela L., Suelves J.M. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction 2002, 97:319-327.
11. Brugal M.T., Domingo-Salvany A., Puig R., Barrio G., Garcia de Olalla P., de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005, 100:981-989.
12. Centers for Disease Control and Prevention Vital signs: overdoses of prescription opioid pain relievers and other drugs among women - United States, 1999-2010. MMWR 2013, 62:537-542.
13. Cerdá M., Ransome Y., Keyes K.M., Koenen K.C., Tracy M., Tardiff K.J., Vlahov D., Galea S. Prescription opioid mortality trends in New York City, 1990-2006: examining the emergence of an epidemic. Drug Alcohol Depend. 2013, 132:53-62.
14. Chang Z., Lichtenstein P., Larsson H., Fazel S. Substance use disorders, psychiatric disorders, and mortality after release from prison: a nationwide longitudinal cohort study. Lancet Psychiatry 2015, 2:422-430.
15. Cruickshank C.C., Dyer K.R. A review of the clinical pharmacology of methamphetamine. Addiction 2009, 104:1085-1099.
16. Darke S., Ross J. Overdose among heroin users in Sydney, Australia: prevalence and correlates of non-fatal overdose. Addiction 1996, 91:405-412.
17. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998, 51:253-263.
18. Darke S., Hall W. Heroin overdose: research and evidence-based intervention. J. Urban Health 2003, 80:189-200.
19. Darke S., Williamson A., Ross J., Mills K.L., Havard A., Teesson M. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study. J. Urban Health 2007, 84:283-291.
20. Darke S., Kaye S., McKetin R., Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008, 27:253-262.
21. Darke S., Mills K.L., Ross J., Teesson M. Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009. Drug Alcohol Depend. 2011, 115:190-195.
22. Davidson P.J., Ochoa K.C., Hahn J.A., Evans J.L., Moss A.R. Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. Addiction 2002, 97:1511-1516.
23. Davoli M., Bargagli A.M., Perucci C.A., Schifano P., Belleudi V., Hickman M., Salamina G., Diecidue R., Vigna-Taglianti F., Faggiano F. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction 2007, 102:1954-1959.
24. Degenhardt L., Larney S., Kimber J., Gisev N., Farrell M., Dobbins T., Weatherburn D.J., Gibson A., Mattick R., Butler T. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. Addiction 2014, 109:1306-1317.
25. Dietze P.M., Jolley D., Fry C., Bammer G. Transient changes in behaviour lead to heroin overdose: results from a case-crossover study of non-fatal overdose. Addiction 2005, 100:636-642.
26. Farrell M., Neeleman J., Griffiths P., Strang J. Suicide and overdose among opiate addicts. Addiction 1996, 91:321-323.
27. Farrell M., Marsden J. Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 2008, 103:251-255.
28. Fazel S., Bains P., Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 2006, 101:181-191.
29. Gossop M., Griffiths P., Powis B., Williamson S., Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ 1996, 313:402.
30. Heilbronn C., Gao C.X., Lloyd B., Smith K., Best D., Lubman D.I. Trends in amphetamine-related harms in Victoria. Med. J. Aust. 2013, 199:395.
31. Hobbs M., Krazlan K., Ridout S., Mai Q., Knuiman M., Chapman R. Mortality and morbidity in prisoners after release from prison in Western Australia 1995-2003. Trends Iss. Crime Crim. Justice 2006, 320:1-6.
32. Kaye S., Darke S. Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. Addiction 2004, 99:1315-1322.
33. Kerr T., Fairbairn N., Tyndall M., Marsh D., Li K., Montaner J., Wood E. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007, 87:39-45.
34. Kinner S.A. Continuity of health impairment and substance misuse among adult prisoners in Queensland, Australia. Int. J. Prison. Health 2006, 2:101-113.
35. Kinner S.A., Milloy M.J., Wood E., Qi J., Zhang R., Kerr T. Incidence and risk factors for non-fatal overdose among a cohort of recently incarcerated illicit drug users. Addict. Behav. 2012, 37:691-696.
36. Kinner S.A., Forsyth S., Williams G. Systematic review of record linkage studies of mortality in ex-prisoners: why (good) methods matter. Addiction 2013, 108:38-49.
37. Kinner S.A., Lennox N., Williams G.M., Carroll M., Quinn B., Boyle F.M., Alati R. Randomised controlled trial of a service brokerage intervention for ex-prisoners in Australia. Contemp. Clin. Trials 2013, 36:198-206.
38. Kinner S.A., van Dooren K., Boyle F.M., Longo M., Lennox N. Development of an intervention to increase health service utilisation in ex-prisoners. Health Justice 2014, 2:1-8.
39. Lake S., Hayashi K., Milloy M.J., Wood E., Dong H., Montaner J., Kerr T. Associations between childhood trauma and non-fatal overdose among people who inject drugs. Addict. Behav. 2015, 43:83-88.
40. Merrall E.L.C., Kariminia A., Binswanger I.A., Hobbs M.S., Farrell M., Marsden J., Hutchinson S.J., Bird S.M. Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010, 105:1545-1554.
41. Milloy M.-J., Kerr T., Mathias R., Zhang R., Montaner J.S., Tyndall M., Wood E. Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. Am. J. Drug Alcohol Abuse 2008, 34:499-509.
42. Ochoa K.C., Davidson P.J., Evans J.L., Hahn J.A., Page-Shafer K., Moss A.R. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend. 2005, 80:297-302.
43. Pierce M., Bird S.M., Hickman M., Millar T. National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005-2009. Drug Alcohol Depend. 2015, 146:17-23.
44. Pollini R.A., McCall L., Mehta S.H., Vlahov D., Strathdee S.A. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006, 83:104-110.
45. Rossow I., Lauritzen G. Balancing on the edge of death: suicide attempts and life-threatening overdoses among drug addicts. Addiction 1999, 94:209-219.
46. Scott N., Caulkins J.P., Ritter A., Quinn C., Dietze P. High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia. Addiction 2015, 110:120-128.
47. Seal K.H., Kral A.H., Gee L., Moore L.D., Bluthenthal R.N., Lorvick J., Edlin B.R. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay area, 1998-1999. Am. J. Public Health 2001, 91:1842-1846.
48. Singleton N., Pendry E., Taylor C., Farrell M., Marsden J. Drug-Related Mortality Among Newly Released Offenders 2003, UK Home Office, London.
49. Stoové M.A., Dietze P.M., Jolley D. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data. Drug Alcohol Rev. 2009, 28:347-352.
50. Strang J., McCambridge J., Best D., Beswick T., Bearn J., Rees S., Gossop M. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ 2003, 326:959-960.
51. Strang J., Manning V., Mayet S., Best D., Titherington E., Santana L., Offor E., Semmler C. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 2008, 103:1648-1657.
52. Strang J., Bird S.M., Parmar M.K. Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial. J. Urban Health 2013, 90:983-996.
53. van Ameijden E.J.C., Langendam M.W., Coutinho R.A. Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addict. Behav. 1999, 24:559-563.
54. Warner-Smith M., Darke S., Day C. Morbidity associated with non-fatal heroin overdose. Addiction 2002, 97:963-967.